ComPro Pharma
ActiveSummary
ComPro Pharma has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €9,170 and a net result of €54,298. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 21% of 610 sector peers (NACE 72, fiscal year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
Directors
Directors
No directors read yet: 0 of 1 Gazette act processed. See the function holders in the CBE →
Owners and capital
Owners
No owners or capital events in the accounts and acts we read.